ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 868

Illness Perceptions Among Patients with Different Forms of Vasculitis

Peter C. Grayson1, Naomi Amudala2, Carol McAlear3, Renée Leduc4, Denise Shereff5, Rachel Richesson6, Liana Fraenkel7 and Peter A. Merkel8, 1Section of Rheumatology & the Clinical Epidemiology Unit, Boston University School of Medicine, Vasculitis Center, Boston, MA, 2Rheumatology & Vasculitis, Boston University Medical Center, Boston, MA, 3Vasculitis Clinical Research Consortium, University of Pennsylvania, Philadelphia, PA, 4Pediatrics Epidemiology Center, University of South Florida, Tampa, FL, 5Division of Bioinformatics and Biostatistics, University of South Florida, Tampa, FL, 6Epidemiology & Biostatistics, University of South Florida, Tampa, FL, 7Medicine, Section of Rheumatology, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare System, New Haven, CT, 8University of Pennsylvania, Philadelphia, PA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Psychosocial and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Psychological Aspects of Rheumatologic Disease

Session Type: Abstract Submissions (ARHP)

Background/Purpose: Patient-held beliefs about their illness are central for understanding patient reactions to specific diseases. This study aimed to compare illness perceptions, defined as the organized cognitive beliefs patients hold about disease, among different forms of vasculitis and to identify risk factors for negative illness perceptions.

Methods: Participants were recruited from an online registry in vasculitis to complete the revised Illness Perception Questionnaire (IPQ-R) which measures dimensions of illness perception. High scores on the identity, timeline, cyclical, consequences, and emotional representations dimensions represent strongly held beliefs about the number of symptoms attributed to illness, the chronicity and cyclical nature of the condition, the negative consequences of illness, and the negative emotional impact of disease. High scores on the personal control, treatment control and illness coherence dimensions represent positive beliefs about the controllability of the illness and personal understanding of the condition. Mean scores in IPQ-R dimensions were compared across types of vasculitis where n>30 and to literature-reported IPQ-R scores in diabetes mellitus, hypertension, and osteoarthritis using ANOVA with post-hoc Scheffe tests. Cluster analysis of IPQ-R scores was used to identify a group with negative illness perceptions, and stepwise regression was used to identify clinical variables (age, sex, race, ethnicity, place of birth, education, income, depression) and disease characteristics (activity status, severity, duration, overall health) associated with negative illness perception.

Results: 692 participants with 9 forms of vasculitis completed the IPQ-R. For 6 dimensions, there were no significant differences in mean IPQ-R scores between the different vasculitides.  Scores in identity and cyclical dimensions were significantly higher in Behçet’s disease compared to other types of vasculitis (13.5 vs 10.7; 4.0 vs 3.2, p<0.05). Compared to other chronic diseases, patients with vasculitis perceived greater negative disease impact on function and emotional well-being (Table). Younger age (OR=1.04; 95%CI 1.02-1.06), depression (OR=4.94; 95%CI 2.90-8.41), active disease status (OR=2.05; 95%CI 1.27-3.29), and poor overall health (OR=3.92; 95%CI 0.88-17.56) were significantly associated with negative illness perception.

Conclusion: Patients with vasculitis have a unique set of illness perceptions. Clinicians should be aware that younger age, a history of depression, active disease status, and poor overall health are risk factors for negative illness perceptions in systemic vasculitis. Given the similarities in illness perceptions across the vasculitides, ongoing efforts to derive patient-reported outcome measures in vasculitis should focus on measures that are universally applied to different types of vasculitis.

 

Table: Mean IPQ-R Dimension Scores in Vasculitis and Other Chronic Diseases
  Vasculitis* Diabetes a Hypertensionb Osteoarthritisc
  n = 692 n = 164 n = 514 n = 241
Identity** 10.7 (±5.1) NC N C N C
Timeline 4.1 (±0.8) 3.9 (±0.8) 3.6 (±0.4) 4.2 (±0.8)
Cyclical 3.2 (±1.0) 2.8 (±0.7) 3.2 (±0.8) 3.6 (±0.8)
Consequences*** 3.8 (±0.8) 2.9 (±0.6) 2.6 (±0.6) 2.8 (±0.8)
Emotional repr.*** 3.1 (±1.0) 2.0 (±0.6) 2.6 (±0.7) 2.4 (±0.8)
Personal control 3.3 (±0.8) 3.9 (±0.6) 3.5 (±0.7) 3.1 (±0.6)
Treatment control 3.3 (±0.7) 4.6 (±0.9) 3.5 (±0.6) 2.8 (±0.6)
Illness coherence 3.4 (±1.0) 3.5 (±0.9) NR 3.6 (±0.8)

* Vasculitis types include Behçet’s disease (n=48), central nervous system vasculitis (n=12), Churg-Strauss syndrome (n=121), giant cell arteritis (n=32), Henoch-Schönlein purpura (n=12), microscopic polyangiitis (n=42), polyarteritis nodosa (n=36), Takayasu’s arteritis (n=57), and granulomatosis with polyangiitis (n=332). ** Identity was scored on scale from 0-22. All other dimensions were scored on a scale from 1-5.  *** Difference between vascultis and all other diseases (p<0.05). NC = not comparable across diseases due to disease-specific modifications to IPQ-R. NR = not reported. a = Searle, J of Psych Res, 2007; b = Ross, J of Hum Hypertension, 2004; c = Bijsterbosch, A&R, 2009.  

 

Disclosure:

P. C. Grayson,
None;

N. Amudala,
None;

C. McAlear,
None;

R. Leduc,
None;

D. Shereff,
None;

R. Richesson,
None;

L. Fraenkel,
None;

P. A. Merkel,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/illness-perceptions-among-patients-with-different-forms-of-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology